| 英文名称 | 中文名称 | CAS |
|---|---|---|
| BKM-120 | 1202777-78-3 | |
| MG-132 | MG132,蛋白酶体抑制剂;MG-132;Z-LEU-LEU-LEU-AL;N-[(苄氧基)羰基]-L-亮氨酰-N-[(1S)-1-甲酰基-3-甲基丁基]-L-亮氨酰胺 | 133407-82-6 |
| PX-866 | 502632-66-8 | |
| RDEA119;BAY-869766;RefaMetinib;RDEA-119 (BAY-869766);BAY 8697661;RefaMetinib/BAY 8697661 | 923032-37-5 | |
| Regorafenib;BAY 73-4506 | 4-[4-({[4-氯-3-(三氟甲基)苯基]氨基甲酰}氨基)-3-氟苯氧基]-N-甲基吡啶-2-甲酰胺;REGORAFENIB BAY 73-4506 BAYER HEALTHCARE (SEE ALSO COLORECTAL, LUNG, STOMACH) PHASE II(REGORAFENIB) PHARMACEUTICALS (888) 842-2937WAYNE, NJ;瑞格非尼(FREE BASE);瑞格非尼;瑞格非尼REGORAFENIB;瑞格菲尼;瑞格非尼:瑞格菲尼;瑞戈非尼 | 755037-03-7 |
| RN-486 | 1242156-23-5 | |
| RO-5126766 | 946128-88-7 | |
| Y-27632 | Y-27632二盐酸盐;4-[(1R)-1-氨基乙基]-N-(吡啶-4-基)环己烷-1-甲酰胺二盐酸盐 | 146986-50-7 |
| GSK-126 | 1346574-57-9 | |
| SB-216763 | 3-(2,4-二氯苯基)-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮 | 280744-09-4 |
| SB-939 | (2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺;(E)-3-(2-BUTYL-1-(2-(DIETHYLAMINO)ETHYL)-1H-BENZO[D]IMIDAZOL-5-YL)-N-HYDROXYACRYLAMIDE;(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺 (SB 939) | 929016-96-6 |
| SCH-772984 | (R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺;1-(2-氧代-2-(4-(4-(嘧啶-2-基)苯基)哌嗪-1-基)乙基)吡咯烷-3-甲酸(R)-甲酯;(3R)-1-[2-氧代-2-[4-[4-(2-嘧啶基)苯基]-1-哌嗪基]乙基]-N-[3-(4-吡啶基)-1H-吲唑-5-基]-3-吡咯烷甲酰胺;(R)-1-(2-氧代-2-(4-(4-(2-嘧啶L)苯基)-L-哌嗪)乙基)-3-[N- | 942183-80-4 |
| SCH-900776 | 891494-64-7 | |
| SGI-1776 | N-[(1-甲基-4-哌啶基)甲基]-3-[3-(三氟甲氧基)苯基]-咪唑并[1,2-B]哒嗪-6-胺;N-[(1-甲基-4-哌啶基)甲基]-3-[3-(三氟甲氧基)苯基]咪唑并[1,2-B]吡嗪-6-胺 | 1025065-69-3 |
| Sorafenib | 索拉非尼;4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺;对甲苯磺酸索拉非尼;索拉菲尼;索+E51拉尼;索拉非尼碱;索拉替尼;索拉菲尼碱 | 284461-73-0 |
| AM-2282 | 星孢菌素;链霉菌属十字孢碱;十字孢碱;链霉菌属十字孢碱分子生物学试剂;十字孢碱,99+%;十字胞碱;星形孢菌素;星胞菌素 | 62996-74-1 |
| Sunitinib malate | N-(2-(二乙基氨基)乙基)-5-((Z)-(5-氟-1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基)-2,4-二甲基-1H-吡咯-3-甲酰胺 (2S)-羟基丁二酸盐;苹果酸舒尼替尼;苏尼替尼苹果酸盐;SU11248; SUTENT;苹果酸舒尼替尼盐;N-(2-(二乙基氨基)乙基)-(5-氟-1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基-2,4-二甲基-1H-吡咯-3-羧酸酰胺 | 341031-54-7 |
| TAK-632 | N-(7-CYANO-6-(4-FLUORO-3-(2-(3-(TRIFLUOROMETHYL)PHENYL)ACETAMIDO)PHENOXY)BENZO[D]THIAZOL-2-YL)CYCLOPROPANECARBOXAMIDE;N-[7-氰基-6-[4-氟-3-[[[3-(三氟甲基)苯基]乙酰基]氨基]苯氧基]-1,3-苯并噻唑-2-基]环丙烷甲酰胺;N-[7-氰基-6-[4-氟-3-[[[3-(三氟甲基)苯基]乙酰基]氨基]苯氧基]-1,3-苯并噻唑-2-基]环丙烷甲酰胺(TAK-632) | 1228591-30-7 |
| Talarozole | N-[4-[(1R)-2-乙基-1-(1H-1,2,4-三唑-1-基)丁基]苯基]-2-苯并噻唑胺;他拉罗唑 | 870093-23-5 |
| Docetaxel | 多烯他赛 ;多烯紫杉醇三水合物(非药典标准品);多西紫杉醇;多西他塞;多似紫杉醇(无水);紫杉特尔;多希紫杉醇;多烯紫杉醇 | 114977-28-5 |
| (+)-JQ-1 | 1268524-70-4 | |
| GDC-0941 | 2-(1H-吲唑-4-基)-6-[[4-(甲基磺酰基)-1-哌嗪基]甲基]-4-(4-吗啉基)噻吩并[3,2-D]嘧啶 | 957054-30-7 |
| Tubacin | 537049-40-4 | |
| VE-822 | 3-[3-[4-[(甲基氨基)甲基]苯基]-5-异恶唑基]-5-[4-[异丙磺酰基]苯基]-2-吡嗪胺 | 1232416-25-9 |
| Bortezomib | 保特佐米;[(1R)-3-甲基-1-[[(2S)-1-氧-3-苯基-2-[(吡嗪甲酰)氨基]丙基]氨基]丁基]-硼酸;硼替佐米;BORTEZOMIB; MG-341; PS-341;硼替佐米/保特佐米;包特左米;保特佐米,硼替佐米;10MG/50MG/1G | 179324-69-7 |
| Verteporfin | 129497-78-5 | |
| VTX-2337 | 926927-61-9 | |
| XL518;GDC-0973;RG7420;CobiMetinib | [3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯基][3-羟基-3-(2S)-2-哌啶基-1-氮杂环丁基]甲酮;克吡替尼 | 934660-93-2 |
| XL-765,SAR245409;XL765;SAR245409;XL765(Voxtalisib) | N-[2-[(3,5-二甲氧基苯基)氨基]喹喔啉-3-基]-4-[(4-甲基-3-甲氧基苯基)羰基]氨基苯磺酰胺;N-[2-[(3,5-二甲氧基苯基)氨基]喹喔啉-3-基]-4-[(4-甲基-3-甲氧基苯基)羰基]氨基苯磺酰胺(XL-765, SAR245409) | 1123889-87-1 |
| YK-4-279 | 4,7-二氯-1,3-二氢-3-羟基-3-[2-(4-甲氧基苯基)-2-氧代乙基]-2H-吲哚-2-酮 | 1037184-44-3 |
| AM-5992 | ||
| AZD9291 mesylate | 1421373-66-1 | |
| CFI-400945 fumarate | ||
| Curaxin (CBL-0137) | ||
| EFT-508 | 1849590-01-7 | |
| Lomequatrib | ||
| LY-3154567 | ||
| Mertansine (DM1) | ||
| MK-2260 | ||
| PRI-724 | ||
| RDEA-436 | ||
| Rocaqlamide | ||
| S63845 | 1799633-27-4 | |
| AMG-51 | 890019-63-3 | |
| IPI-549 | 1693758-51-8 | |
| BAY-1082439 | ||
| CCT245737 | 1489389-18-5 | |
| Sapacitabine | N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺 | 151823-14-2 |
| BAY-1436032 | ||
| LY-3177833 | 1627696-51-8 | |
| G1T28(Trilaciclib) | ||
| E-7090 | ||
| X-396 | 1365267-27-1 |
联系方式
